No Data
No Data
Express News | Iteos and GSK Initiate Galaxies Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic Pd-L1 Selected Non-Small Cell Lung Cancer
J.P. Morgan Maintains ITeos Therapeutics(ITOS.US) With Buy Rating
J.P. Morgan analyst Brian Cheng maintains $ITeos Therapeutics(ITOS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 31.2% and a total average return of -18.7% over
We Think ITeos Therapeutics, Inc.'s (NASDAQ:ITOS) CEO Compensation Package Needs To Be Put Under A Microscope
10 Health Care Stocks With Whale Alerts In Today's Session
ITeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy
Merck Discontinues Testing of Experimental Skin Cancer Combo Therapy